Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.novartis.in | |
Market Cap | 1,575.52 Cr. | |
Enterprise Value(EV) | 1,010.38 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 21.75 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | 29.33 | Trailing Twelve Months Ending 2022-09 |
Industry PE | 32.54 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 299.19 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 2.13 | Calculated using Price: 638.10 |
Dividend Yield | 1.57 | Period Ending 2022-03 |
No. of Shares Subscribed | 2.47 Cr. | 24,690,797 Shares |
FaceValue | 5 | |
Company Profile | ||
Novartis has been in India since 1947. The Group operates in India through four entities namely Novartis India Limited, listed on the Mumbai Stock Exchange, Novartis Healthcare Private Limited, Sandoz Private Limited and Chiron-Behring Vaccine Private Limited. In India Novartis have a presence in pharmaceuticals, generics (pharmaceutical products that are off patent), Vaccines, OTC (over-the-counter medicines), eyecare and Animal Health. |
1 Day |
|
+4.47% |
1 Week |
|
+0.12% |
1 Month |
|
-5.04% |
3 Month |
|
-5.74% |
6 Month |
|
-11.31% |
1 Year |
|
-13.43% |
2 Year |
|
-2.07% |
5 Year |
|
+0.23% |
10 Year |
|
-0.56% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 10.59 | 8.06 | 18.01 | 5.38 | 9.40 | 6.89 | 1.36 | 2.91 | -0.53 | |
Return on Capital Employed (%) | 9.69 | 9.52 | 24.77 | 8.75 | 19.72 | 11.70 | 4.73 | 6.67 | 0.14 | |
Return on Assets (%) | 4.98 | 3.89 | 11.38 | 3.27 | 3.75 | 2.51 | 0.62 | 1.22 | -0.18 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 961 | 1,002 | 1,194 | 920 | 734 | 759 | 721 | 711 | 692 | 739 | |
Non Curr. Liab. | 586 | 697 | 26 | 828 | 898 | 891 | 99 | 1,131 | 1,000 | 32 | |
Curr. Liab. | 459 | 362 | 204 | 323 | 482 | 367 | 417 | 357 | 334 | 204 | |
Minority Int. | |||||||||||
Equity & Liab. | 2,006 | 2,060 | 1,425 | 2,070 | 2,113 | 2,018 | 1,237 | 2,199 | 2,026 | 974 | |
Non Curr. Assets | 698 | 846 | 161 | 959 | 1,009 | 1,029 | 240 | 1,277 | 1,199 | 224 | |
Curr. Assets | 1,308 | 1,215 | 1,264 | 1,111 | 1,104 | 989 | 997 | 922 | 827 | 750 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 2,006 | 2,060 | 1,425 | 2,070 | 2,113 | 2,018 | 1,237 | 2,199 | 2,026 | 974 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 862 | 873 | 690 | 656 | 564 | 491 | 438 | 381 | 400 | 420 | |
Other Income | 97 | 112 | 245 | 72 | 174 | 78 | 36 | 34 | 35 | 54 | |
Total Income | 959 | 985 | 934 | 728 | 738 | 569 | 475 | 416 | 435 | 473 | |
Total Expenditure | -866 | -881 | -659 | -632 | -572 | -479 | -427 | -356 | -374 | -359 | |
PBIDT | 94 | 104 | 275 | 96 | 166 | 91 | 48 | 60 | 60 | 114 | |
Interest | 0 | 0 | 0 | -1 | -6 | -2 | -6 | -8 | -5 | -3 | |
Depreciation | -4 | -4 | -3 | -4 | -3 | -3 | -13 | -12 | -10 | -7 | |
Taxation | 9 | -14 | -73 | -35 | -79 | -34 | -19 | -19 | 0 | -1 | |
Exceptional Items | -6 | -50 | -50 | ||||||||
PAT | 99 | 79 | 198 | 57 | 78 | 52 | 10 | 21 | -4 | 54 | |
Adjusted EPS | 31 | 25 | 62 | 20 | 32 | 21 | 4 | 8 | -2 | 22 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 7 | -5 | -60 | 57 | -41 | 161 | -194 | -23 | -69 | 39 | |
Cash Fr. Inv. | -16 | 22 | 719 | -630 | 424 | 69 | 274 | 56 | 95 | 87 | |
Cash Fr. Finan. | -37 | -38 | -38 | -39 | -332 | -268 | -30 | -41 | -37 | -36 | |
Net Change | -46 | -20 | 622 | -612 | 51 | -38 | 50 | -9 | -11 | 90 | |
Cash & Cash Eqvt | 36 | 15 | 637 | 25 | 76 | 38 | 88 | 79 | 68 | 158 |
Mon, 30 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 |
Tue, 17 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 |
Fri, 13 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 |
Tue, 31 Jan 2023 |
|
|
|
|
|